Miodrag Dragoj

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

Top Venues

Diagnostics (Basel, Switzerland)

Histochemistry and cell biology

This page only lists publications with an associated author ORCID identifier.

Publications

Jelena Dinic, Miodrag Dragoj, Sofija Jovanović Stojanov, Ana Stepanović, Ema Lupšić, Milica Pajović, Thomas Mohr, Sofija Glumac, Dragana Marić, Maja Ercegovac, Ana Podolski-Renić, Milica Pesic
Multidrug-Resistant Profiles in Non-Small Cell Lung Carcinoma Patient-Derived Cells: Implications for Personalized Approaches with Tyrosine Kinase Inhibitors. Cancers 16 (11) (2024)
Jelena Dinic, Miodrag Dragoj, Sofija Jovanović Stojanov, Ana Stepanović, Ema Lupšić, Milica Pajović, Thomas Mohr, Sofija Glumac, Dragana Marić, Maja Ercegovac, Ana Podolski-Renić, Milica Pesic
Multidrug-Resistant Profiles in Non-Small Cell Lung Carcinoma Patient-Derived Cells: Implications for Personalized Approaches with Tyrosine Kinase Inhibitors. Cancers 16 (11) (2024)
Jelena Dinic, Ana Podolski-Renić, Miodrag Dragoj, Sofija Jovanović Stojanov, Ana Stepanović, Ema Lupšić, Milica Pajović, Mirna Jovanović, Dušica Petrović Rodić, Dragana Marić, Maja Ercegovac, Milica Pesic
Immunofluorescence-Based Assay for High-Throughput Analysis of Multidrug Resistance Markers in Non-Small Cell Lung Carcinoma Patient-Derived Cells. Diagnostics (Basel, Switzerland) 13 (24) (2023)
Jelena Dinic, Ana Podolski-Renić, Miodrag Dragoj, Sofija Jovanović Stojanov, Ana Stepanović, Ema Lupšić, Milica Pajović, Mirna Jovanović, Dušica Petrović Rodić, Dragana Marić, Maja Ercegovac, Milica Pesic
Immunofluorescence-Based Assay for High-Throughput Analysis of Multidrug Resistance Markers in Non-Small Cell Lung Carcinoma Patient-Derived Cells. Diagnostics (Basel, Switzerland) 13 (24) (2023)
Jelena Dinic, Ana Podolski-Renić, Miodrag Dragoj, Sofija Jovanović Stojanov, Ana Stepanović, Ema Lupšić, Milica Pajović, Mirna Jovanović, Dušica Petrović Rodić, Dragana Marić, Maja Ercegovac, Milica Pesic
Immunofluorescence-Based Assay for High-Throughput Analysis of Multidrug Resistance Markers in Non-Small Cell Lung Carcinoma Patient-Derived Cells. Diagnostics (Basel, Switzerland) 13 (24) (2023)
Mirna Jovanović, Tijana Stanković, Sonja Stojković Burić, Jasna Banković, Jelena Dinic, Mila Ljujić, Milica Pesic, Miodrag Dragoj
Decreased TSPAN14 Expression Contributes to NSCLC Progression. Life (Basel, Switzerland) 12 (9) (2022)
Berta Segura-Collar, Juan Jiménez-Sanchez, Ricardo Gargini, Miodrag Dragoj, Juan Manuel Sepúlveda Sánchez, Milica Pesic, María A Ramírez, Luis E Ayala-Hernández, Vicente A Torres, Victor M Pérez-García
On optimal temozolomide scheduling for slowly growing glioblastomas. Neuro-oncology advances 4 (1) (2022)
Aleksandra Divac Rankov, Sofija Jovanović Stojanov, Miodrag Dragoj, Mila Ljujić
Alpha-1 antitrypsin expression is upregulated in multidrug-resistant cancer cells. Histochemistry and cell biology (2022)
Ana Kostić, Sofija Jovanović Stojanov, Ana Podolski-Renić, Marija Stepanović, Miodrag Dragoj, Igor Nikolić, Goran Tasić, Silvia Schenone, Milica Pesic, Jelena Dinic
Pyrazolo[3,4-d]pyrimidine Tyrosine Kinase Inhibitors Induce Oxidative Stress in Patient-Derived Glioblastoma Cells. Brain sciences 11 (7) (2021)
Miodrag Dragoj, Jasmina Stojkovska, Tijana Stanković, Jelena Dinic, Ana Podolski-Renić, Bojana Obradović, Milica Pesic
Development and Validation of a Long-Term 3D Glioblastoma Cell Culture in Alginate Microfibers as a Novel Bio-Mimicking Model System for Preclinical Drug Testing. Brain sciences 11 (8) (2021)
Petar Stupar, Ana Podolski-Renić, Maria Ines Villalba, Miodrag Dragoj, Sofija Jovanović Stojanov, Milica Pesic, Sandor Kasas
Nano-Motion Analysis for Rapid and Label Free Assessing of Cancer Cell Sensitivity to Chemotherapeutics. Medicina (Kaunas, Lithuania) 57 (5) (2021)